EarningsQ3 2024 Earnings Report

ACADIA Pharmaceuticals (ACAD) Q3 2024 Earnings Report

0 Followers

MX:ACAD Q3 2024 EPS Results

Actual EPS$3.60

Consensus EPS$2.48

Beat/MissBeat by +$1.12

One Year Ago EPS-$7.20

Actual Revenue$4.51B

Expected Revenue$4.48B

Beat/MissBeat by +$28.29M

YoY Revenue Growth+18.28%

QuarterQ3 2024

Date11/06/2024

TimeAfter Close

Conference CallWednesday, November 6, 2024

MX:ACAD Upcoming Earnings

ACADIA Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:ACAD Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	3.56 / -	7.562	―
Aug 04, 2026	2026 (Q2)	1.22 / 3.24	2.881	12.50% (+0.36)
May 06, 2026	2026 (Q1)	0.92 / 0.36	1.981	-81.82% (-1.62)
Feb 25, 2026	2025 (Q4)	2.47 / 28.81	15.484	86.05% (+13.32)
Nov 05, 2025	2025 (Q3)	3.11 / 7.56	3.601	110.00% (+3.96)
Aug 06, 2025	2025 (Q2)	2.48 / 2.88	3.601	-20.00% (-0.72)
May 07, 2025	2025 (Q1)	1.57 / 1.98	1.8	10.00% (+0.18)
Feb 26, 2025	2024 (Q4)	3.89 / 15.48	5.041	207.14% (+10.44)
Nov 06, 2024	2024 (Q3)	2.48 / 3.60	-7.202	150.00% (+10.80)
Aug 06, 2024	2024 (Q2)	3.20 / 3.60	0.18	1900.00% (+3.42)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed